Research groups
Yama Mujadidi
BCA Computer Application , MSc in Information Technology and Software Engineering
Clinical Trials IT and Development Lead
Yama F Mujadidi has expertise in the design and development of software and is currently working with Oxford Vaccine Group in the capacity of Clinical Trials IT and Development Lead. He acquired an MSc in Information Technology from University of Bradford United Kingdom, in 2012 after he earned a First class degree in BCA Computer Application from the University of Pune, in the year 2010.
Yama joined Oxford Vaccine Group in June 2013 and tasked to provide specialist advice to research groups to improve quality of clinical trials and to develop an application based on the vaccine knowledge project for use in smart-phones/tablets. Before Oxford Vaccine Group, He had been working with Omni Communication Product Limited as a software developer and contributed to the development of a multi-communication application for use in smartphones and tablets.
Recent publications
-
Journal article
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
-
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial.
Journal article
LAMBE T. et al, (2020), Nature Medicine
-
Journal article
Gibani MM. et al, (2020), PLoS Negl Trop Dis, 14
-
Journal article
Thindwa D. et al, (2020), Wellcome open research, 5, 66 - 66
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Internet publication
MUJADIDI YF., (2020)
-
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants
Internet publication
Valente Pinto M. et al, (2020)
-
Journal article
Thindwa D. et al, (2020), Wellcome Open Research, 5, 66 - 66
-
Journal article
Barrett JR. et al, (2020), Nat Med
-
Journal article
Winkler C. et al, (2019), Pediatr Diabetes, 20, 720 - 727
-
Journal article
Theiss-Nyland K. et al, (2019), Clinical Infectious Diseases, 68, S74 - S82
-
Journal article
Theiss-Nyland K. et al, (2019), Clinical Infectious Diseases, 68, S67 - S73
-
Journal article
Colin-Jones R. et al, (2019), Clinical Infectious Diseases, 68, S138 - S145
-
Journal article
Shakya M. et al, (2019), New England Journal of Medicine, 381, 2209 - 2218
-
Journal article
Voysey M. et al, (2015), Vaccine, 33, 7203 - 7210